Contact

TELEPHONE
FAX
82-2-515-6631
ADDRESS
41 GYEOMJAE-RO, 22 GIL, JUNGNANG-GU, SEOUL 131-821, REPUBLIC OF KOREA

Clinical Evidence

OUYE with Lidocaine has received official approval of its effectiveness in anti-wrinkles and safety through comparative clinical trials conducted by major university hospitals in Korea under the approval of the medical device clinical trial from Ministry of Food and Drug Safety.

Comparison of Global Aesthetic Improvement (GAI) Estimated by Investigator

+8 weeks +16 weeks +24 weeks
OUYE with Lidocaine
(experimental group)
1,6 ± 0,63 1,59 ± 0,74 1,37 ± 0,57
Product R
(control group)
1,59 ± 0,63 1,59 ± 0,74 1,37 ± 0,57

Comparison of Global Aesthetic Improvement (GAI) Estimated by Subject

+8 weeks +16 weeks +24 weeks
OUYE with Lidocaine
(experimental group)
1,47 ± 0,84 1,41 ± 0,92 1,31 ± 0,92
Product R
(control group)
1,53 ± 0,78 1,42 ± 0,90 1,19 ± 0,98

Minimum BDDE & 3D Linking

3D cross linked hyaluronic acid dermal filler

  • OUYE with Lidocaineuse non-animal based hyaluronic acid having a molecular weight of 2,500,000 Da as the ingredient
  • Optimum viscosity and elasticity are achieved simultaneously by applying OUYE with Lidocaine’s unique technology which is capable of making 3D structure using a small amount of cross-linking agent.

BDDE residue and endotoxin are strictly processed under careful control

OUYE with Lidocaine is a product with low residue that has achieved safety standards after applying BDDE purification process 4 times.